Comments
Commented by André Will-Laudien on June 21st, 2021 | 12:52 CEST
Porsche, Gazprom, Teck Resources, GSP Resource - The raw materials rally continues!
There was a minor decline on Friday. Rarely could the DAX in recent weeks get caught up in a correction. But on triple witching, it fell from the morning onwards and lost a full 2% to 15,420 points over the course of the day. The all-time high at 15.808 is now a bit removed, and the sidelines also had to give up a bit. The S&P 500 had its first bad week since the significant May correction. However, the chart technicians are still calm; it was probably just a correction in the uptrend. Commodities were largely spared from the correction, Brent and WTI oil at highs near USD 74 and 71 respectively, and copper still just under USD 10,000.
ReadCommented by Nico Popp on June 21st, 2021 | 12:06 CEST
Deutsche Bank, ThyssenKrupp, White Metal Resources: When opportunities arise from legacy issues
What will the market bring in the second half of the year? Will the takeover merry-go-round spin and blue chips continue to climb in the wake of the booming comeback economy? Or do infrastructure programs and further construction drive the steel sector? The chances are good that the economy is again breathing a breath of fresh air and is on the verge of a long-lasting upswing. Traditionally, this upswing is characterized by setbacks, particularly at the beginning. We outline how investors can invest, taking three stocks as examples.
ReadCommented by Nico Popp on June 21st, 2021 | 11:25 CEST
BYD, QMines, Varta: Investors must now think outside the box
E-cars are back! It is not just on the roads that we see more and more electric cars. Shares related to electromobility have also been at the top of the price list again for a few days. After major car manufacturers had already ventured to move toward electromobility months ago, the air was out for some shares. Now, however, the stocks are starting to jump again. In the slipstream of BYD and Co., other shares could pick up. We present some attractive stocks.
ReadCommented by Stefan Feulner on June 21st, 2021 | 10:49 CEST
Palantir, Blackrock Silver, Freenet - Decisive weeks
Uncertainties on the capital markets are increasing, and so is the potential for corrections. The reason is once again the concerns about rampant inflation. After last week's meeting of the US Federal Reserve, key interest rates were left at historic lows, but discussions about curbing bond purchases and possible interest rate hikes as early as 2022 continue to grow. If the FED were to call an end to the ultra-loose monetary policy soon, this would be a fatal sign for the markets with far-reaching consequences.
ReadCommented by Carsten Mainitz on June 18th, 2021 | 15:10 CEST
MorphoSys, Biogen, Sierra Growth - What is next?
Pharmaceutical stocks are a bit like that: Giants like Johnson & Johnson or Novartis have an extensive product portfolio and can cushion failures of individual products quite well. It is often a matter of life and death for smaller, specialized companies with every development. Just yesterday, this could be observed in the CureVac share after its Corona vaccine candidate only achieved an efficacy of 47% in the clinical 2b/3 phase. Within a very short time, it disintegrated the stock price. Meanwhile, biotech pioneer Biogen surprised with an unjustified share price rally, which, however, could come to an abrupt end after a new setback. The situation is different for MorphoSys. Its planned acquisition of Constellation Pharmaceuticals initially weighed heavily on the share price, but it holds exciting potential. And the Canadian mining Company Sierra Growth is operating in a completely different environment; however, it has a top opportunity to offer in the current inflationary environment and should not go unmentioned.
ReadCommented by André Will-Laudien on June 18th, 2021 | 14:39 CEST
Carnival, TUI, Desert Gold - A total upswing or is it all over again?
It is probably one of the strangest travel waves since we could remember. For months we Germans could not leave our own country's borders without great effort; the ski season in 2020/21 fell victim to the COVID pandemic almost completely. Now we experience amazingly low incidences, which probably would have come even without lockdown...but let's take that as a given because some action had to be taken as public proof of action, after all. Now travel is possible again with good conditions for the vaccinated and a bit more cumbersome for recovered, healthy and non-vaccinated. Exciting to observe: How are the travel companies doing now?
ReadCommented by Stefan Feulner on June 18th, 2021 | 13:05 CEST
Adidas, RYU Apparel, About You, Nike - Fully on Trend
When Germany plays France, it is also a battle of Adidas versus Nike. For the sporting goods manufacturers, the European Football Championship is the marketing highlight of this year, alongside the Olympic Games in Tokyo. Trade in sporting goods is booming. The Corona pandemic has made a new trend, sports at home, a crisis winner. Sales, especially online, skyrocketed. This trend is likely to remain even after the gym openings, and it promises enormous growth leaps for manufacturers.
ReadCommented by André Will-Laudien on June 18th, 2021 | 12:49 CEST
CureVac, BioNTech, Novavax, XPhyto Therapeutics - The Covid giants and the sellout!
How quickly the tide can turn in the environment of the Corona pandemic can be seen in the vaccine manufacturers and test providers. BioNTech's share price has been rising steadily since the start of the vaccination campaign in Germany, and minor reports of potential side effects are hardly disturbing. In the case of test provider NanoRepro, the bull market of recent months is turning into a total sell-off, with the share losing over 70%. And then there is the Tübingen-based biotech Company CureVac. Delays in approval and a shock on efficacy send the share down by a whole 50% in one day. We take a closer look at the situation.
ReadCommented by Armin Schulz on June 18th, 2021 | 12:33 CEST
Kodiak Copper, Deutsche Telekom, Varta - What is going on in commodities?
The hype around wood lasted until May 25, after which the rally ended and the price consolidated by a whopping 40%. Gold was trading above USD 1,900 last week. In parallel to this article's writing, the price is below USD 1,800. A minus of about 5.5% within five days, and the industrial metal for electrification and copper, dropped by 8%. Currently, all factors speak for a further increase in commodity prices. Real interest rates are still negative, and inflation should also remain high. The Fed could not help calm the markets, although interest rate hikes were not announced until 2023. However, the Fed intends to continue its bond purchases. Consolidation can always occur after strong increases, and so we will see long-term rising commodity prices, especially for precious metals and copper.
ReadCommented by Stefan Feulner on June 18th, 2021 | 11:34 CEST
Bayer, White Metal Resources, Barrick Gold - Trendsetting news
At Federal Reserve's meeting, runaway inflation was the topic par excellence. With US consumer prices up 5% in May, market participants assumed at least an announcement of a pullback in bond market volume. However, an interest rate hike, which would actually be necessary for price stability, is not considered before 2023, according to FED Chairman Jerome Powell. Thus, through the continued ultra-loose monetary policy, he refers to the attitude that economic growth and a rising stock market are more important than low inflation.
Read